Palo Alto Investors LP

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	1.09%	-2.46%	$8.37M	1.61M	-3,645,299	-69.3%	$5.19	Q3 2024
6/30/2024	1.65%	+0%	$13.5M	5.26M	+9,082	+0.17%	$2.57	Q2 2024
3/31/2024	2.91%	+0.01%	$25.8M	5.25M	+10,720	+0.2%	$4.92	Q1 2024
12/31/2023	4.17%	+0.01%	$46M	5.24M	+8,675	+0.17%	$8.79	Q4 2023
9/30/2023	5.67%		$60M	5.23M			$11.47	Q3 2023
6/30/2023	10.7%	-0.09%	$132M	5.23M	-41,600	-0.79%	$25.31	Q2 2023
3/31/2023	14.1%	-0.04%	$170M	5.27M	-13,400	-0.25%	$32.21	Q1 2023
12/31/2022	8.32%	+1.38%	$97.5M	5.28M	+878,570	+19.9%	$18.46	Q4 2022
9/30/2022	9.4%		$119M	4.41M			$27.00	Q3 2022
6/30/2022	5.31%	-0.01%	$60.9M	4.41M	-10,650	-0.24%	$13.82	Q2 2022
3/31/2022	6.66%	+0.07%	$86.1M	4.42M	+46,323	+1.06%	$19.50	Q1 2022
12/31/2021	4.56%	+1.22%	$71.3M	4.37M	+1,167,500	+36.5%	$16.32	Q4 2021
9/30/2021	5.38%		$89.2M	3.2M			$27.86	Q3 2021
6/30/2021	5.25%		$94.9M	3.2M			$29.64	Q2 2021
3/31/2021	5.1%	+0.84%	$89.5M	3.2M	+528,553	+19.8%	$27.95	Q1 2021
12/31/2020	3.97%	+1.01%	$75.8M	2.67M	+678,408	+34%	$28.34	Q4 2020
9/30/2020	2.75%	+0.4%	$50.2M	1.99M	+290,533	+17%	$25.14	Q3 2020
6/30/2020	2.51%	+1.6%	$41.6M	1.7M	+1,088,667	+177%	$24.42	Q2 2020
3/31/2020	0.76%	+0.65%	$9.11M	616K	+527,115	+595%	$14.80	Q1 2020
12/31/2019	0.08%	+0.08%	$1.44M	88.6K	+88,590	NEW	$16.23	Q4 2019
12/31/2014		-0.12%	$0	0	-80,369	-100%		Q4 2014
9/30/2014	0.12%	-0.02%	$1.55M	80.4K	-11,300	-12.3%	$19.34	Q3 2014
6/30/2014	0.23%		$3.12M	91.7K			$34.00	Q2 2014
3/31/2014	0.24%	+0.24%	$2.89M	91.7K	+91,669	NEW	$31.50	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.